ABSTRAm. Hyperoxic lung injury may be mitigated by increasing alveolar epithelial antioxidant activity. We examined whether intratracheal instillation of superoxide dismutase (SOD) and catalase, conjugated to polyethylene glycol (PEG) to permit cellular access, reduces hyperoxic lung injury. Adult rats, pretreated intratracheally with 1 500 U PEG-SOD and 10 000 U PEG-catalase or with inactivated PEG-SOD/catalase, 1 % PEG, or saline (treated controls), were exposed to hyperoxia (fraction of inspired oxygen > 0.95) for 48 h and compared with untreated air controls. Alveolar wash protein values in the treated control groups were significantly higher than in the PEG-SOD/catalase and air control groups, which had comparable values. Lung homogenate and alveolar type I1 cell SOD and catalase activities were higher after PEC-SOD/catalase treatment and lower after the control treatments when compared with untreated air controls. Lung homogenate dipalmitoyl phosphatidylcholine decreased and alveolar wash dipalmitoyl phosphatidylcholine increased after hyperoxia, but these changes were less after PEG-SOD/catalase treatment. Rats pretreated intratracheally with PEG-SOD/catalase survived significantly longer in hyperoxia than saline controls. These data indicate the potential of intratracheal antioxidant treatment to reduce pulmonary oxygen toxicity. (Pediatr Res 33: 332-335, 1993) Abbreviations DPPC, dipalmitoyl phosphatidylcholine PEG, polyethylene glycol SOD, superoxide dismutase Successful attempts to modify pulmonary oxygen toxicity in adult animals have involved the augmentation of the intracellular antioxidant capacity by endotoxin (l), preexposure to hyperoxia (2, 3) or hypoxia (4), and the administration of exogenous antioxidant enzymes. SOD, catalase, and glutathione peroxidase cooperate in the detoxification of free oxygen radicals. SOD is responsible for the metabolism of superoxide anions; catalase and glutathione peroxidase catalyze the reduction of Hz02 to H20, with glutathione peroxidase also playing a role in the detoxification of intracellular hydroperoxides. Native SOD and catalase injected i.v. (5) or SOD administered intratracheally to rats (6) does not provide protection against hyperoxia, because their large molecular size does not permit penetration across cell membranes and they have a short half-life.
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When the molecular weight of SOD and catalase is increased through covalent attachment of the inert linear polymer, monomethoxy-PEG, they can undergo endocytosis and are taken up by cultured endothelial cells (7) and primary cultures of alveolar type I1 cells (8) , thereby increasing cellular antioxidant enzyme activity and providing protection from the damaging effects of reactive oxygen species. Intravenous administration of PEG-SOD and PEG-catalase to rats (9) and preterm lambs (10) provides partial protection against hyperoxic lung injury. Like PEG-conjugated antioxidants. liposome-encapsulated antioxidant enzymes enter cells in active form, either by fusion with plasma membranes or by endocytosis, and are protective against oxygen toxicity after i.v. or intraperitoneal administration (5, 1 1 ) or addition to alveolar type I1 cells (12. 13) . Liposomal antioxi-1 dant enzymes instilled into the airway of adult rats prolong survival after exposure to hyperoxia (14) . We investigated whether intratracheal instillation of PEG-SOD and PEG-catalase increases the activity of these antioxidant enzymes in lung tissue, especially in alveolar type I1 cells, and reduces pulmonary oxygen toxicity in adult rats.
MATERIALS AND METHODS

1
Chemicals. Native bovine Cu, Zn-SOD and catalase and PEG-SOD and PEG-catalase ( I 5) were obtained from Sigma Chemical Company (St. Louis. MO), elastase was obtained from Worthington Biochemical Corp. (Freehold. NJ). fetal bovine serum from Hyclone Laboratories (Logan, UT), tissue culture media from GIBCO (Grand Island, NY). and plasticware from Falcon (Oxnard, CA). Antioxidant enzyme solutions were shown to be free of endotoxin contamination by the limulus amebocyte lysate assay ( 16, 17) . All other enzymes and biochemicals, of the highest grade available, were obtained from Sigma.
Inacrivafion of PEG-SOD and PEG-catalase. For control experiments, PEG-SOD was inactivated by mixing 10 mg PEG-SOD/mL with 100 mM H202 at room temperature for 6 h. then dialyzed three times for 8 h in potassium phosphate (10 mM) buffered (pH 7.4) saline (0.15 M NaCI) at 4% assayed for activity, filtered (0.22 pM), and stored at 4°C (18). PEG-catalase (10 mg protein/mL) was inactivated by heating at 90°C for 15 min, assayed for activity, passed through a 27-gauge needle, and stored at 4°C. Inactivated PEG-SOD and PEG-catalase lacked SOD and catalase activity when assayed and did not precipitate after inactivation.
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after receiving 30 mg pentobarbital sodium by intraperitoneal injection and having their trachea exposed by an incision in the neck. Test solutions consisted of 0.2 mL of rat surfactant (12.5 ctrnol DPPC/mL) plus 0.1 mL containing 1 500 U of PEG-SOD + 10 000 U PEG-catalase (PEG-SOD/catalase group), equal amounts of inactivated PEG-SOD + PEG-catalase (inactive PEG-SOD/catalase group). 3% PEG ( 1 % PEG group). or normal saline. The rats were then exposed to hyperoxia for 48 h or until they died. Untreated. air-exposed rats were used as baseline controls. Groups of six to eight rats were used for collection of alveolar washes and lung homogenates and groups of four rats were used for type I1 cell isolates after 48 h of hyperoxia. Six untreated. air-exposed rats were used for collection of alveolar washes and lung homogenate and four were used for type 11 cell isolates. Eight pairs of rats (PEG-SOD/catalase and saline groups) were studied for survival in hyperoxia.
Expo.stlre to hyprrosia. After pretreatment, rats were exposed to normobaric hyperoxic conditions (100% 0 2 at a total flow rate sufficient to provide five to seven volume changes per cage per hour) in pairs in air-tight polystyrene cages with an internal volume of 72 L containing Soda-sorb C 0 2 absorbent (Baker, Phillpsburg, NJ) and Drierite (Hammond. Xenia, OH) (19) . Oxygen concentrations were analyzed continuously with an oxygen monitor (Beckman Instruments. Inc., Fullerton, CA) and remained at >95%. Ambient C 0 2 exiting the cages was verified to be <I%. using a Fryrite test kit (Bacharach Instruments. Pittsburgh. PA). Gas was humidified; relative humidity was 60-70% as monitored with a hygrometer and temperatures were 24-26°C. Animals were allowed free access to water and rat food and were monitored by video surveillance. The rats were continuously exposed to hyperoxia for 48 h or until they died, except for a 15-min period each day when the cages were opened for housekeeping purposes. After 48 h of hyperoxia, the clinicopathologic status of the rats was evaluated (20) . A score of 0 (normal). 1 (moderately abnormal), or 2 (markedly abnormal) was given for each of five parameters of pulmonary oxygen toxicity: degree of respiratory distress, pleural fluid quantity, gross presence of lung edema. hemorrhage. and atelectasis (possible total score: 0-10).
.4s.saj1.s. After the rats were killed with an intraperitoneal injection of 100 mg of pentobarbital sodium. the trachea was cannulated. The thorax was opened. the left atrium excised. and the pulmonary artery perfused with 20 mL of ice-cold 0.15 M NaCI. The lungs were lavaged six times with 7 mL of balanced salt solution (pH 7.2) (19) at 37°C and excised. The lung tissue was homogenized in 10 mL of 5 mM potassium phosphate buffer (pH 7.8) containing 1% Triton X-100 for 90 s in a Brinkmann polytron (Brinkmann Instruments. Inc.. Westbury. NY) at high speed or subjected to the elastase digestion. mechanical dissection, and rat IgG differential adherence protocol of Dobbs et a/. (2 I ) to isolate alveolar type 11 cells. Alveolar washes were assayed for protein and DPPC content and SOD and catalase activity. lung homogenates for DNA and DPPC content and SOD and catalase activity. and type I1 cells for DNA content and SOD and catalase activity. In the survival studies. time of death was recorded with the video surveillance system and each rat pretreated with PEG-SOD/catalase was paired with a rat pretreated with saline.
Total SOD activity was assayed by inhibition of the reduction of cytochrome c in the xanthine oxidase reaction (22) using a modification described by Forman and Fisher (23) . Endogenous reductants in the samples. which could interfere with the assay by producing nonsuperoxide-dependent cytochrome c reduction, were eliminated by mixing the sample and 5 x lo-' M cytochrome c in 0.6 mL of 0.5 M potassium phosphate buffer (pH 7.8) and allowing the reduction and reoxidation by endogenous cytochrome oxidase of the cytochrome c to occur. The reaction was followed at 550 nm in a DU-65 spectrophotometer (Beckman Instruments. Inc., Fullerton. CA). After initial incubation.
M cyanide to inhibit cytochrome oxidase was added. followed by xanthine. xanthine oxidase, and H 2 0 to a final volume of 3 mL. One unit of SOD equalled 50% inhibition of cytochrome c reduction. Catalase activity was measured by the rate of reduction of H202 substrate followed spectrophotometrically at 240 nm (24) . One unit was defined as the amount of enzyme degrading 1 ctrnol H202/min and was calculated using an extinction coefficient of 0.046 Fmol/cm' at 240 nm.
The amount of protein in the samples was determined by a modification of the Lowry method (25) using BSA as a standard. DNA was measured using a fluorometric technique and calf thymus DNA as a standard (26) . For analyses of DPPC content, the samples were extracted with chloroform:methanol (27) and the lipid extracts treated with osmic acid precipitation and alumina column chromatography (28) before phosphorus assay (29) . A known quantity of I4C-DPPC (New England Nuclear. Boston. MA) was added before lipid extraction, and aliquots were counted at each step to estimate and correct for sequential losses.
Statistical methods. Lung homogenate and type I1 cell antioxidant enzyme activities were normalized to the actual DNA concentration and expressed as U/mg DNA and DPPC values as mg/g lung or ctg/mL alveolar wash. Results are expressed as mean f SD. Comparisons between various experimental conditions were done using one-way analyses of variance followed by multiple comparisons using the Student-Newman-Keuls test. Clinicopathologic scores and survival time were analyzed with Wilcoxon's rank sum test.
RESULTS
After 48 h of hyperoxia. the mean protein content in the alveolar washes of rats pretreated with PEG-SOD/catalase was similar to that of air controls and significantly lower than in rats treated with inactive PEG-SOD/catalase. 1% PEG. or saline (Fig.  1) . Alveolar wash SOD activity was below detectable levels. but catalase was present in all groups, with higher values in the PEG-SOD/catalase and air control groups (Fig. I) . SOD and catalase activities in lung homogenates (Fig. 2) and in alveolar type I1 cell isolates (Fig. 3 ) from rats treated with PEG-SOD/catalase were higher and in the three treated control groups significantly lower than in air controls. DPPC in lung tissue (Fig. 2) decreased after hyperoxia and was accompanied by an increase in alveolar wash DPPC (Fig. 1) group. Padmanabhan el al. (14) found that intratracheal admin-CATALASE istration of liposome-encapsulated SOD and catalase increased increase in antioxidants in other pulmonary cell types. possibly alveolar type I cells and/or fibroblasts (33) . Lung tissue DPPC less in the rats treated with PEG-SOD/catalase than in the three decreased and alveolar wash DPPC increased after 48 of treated control groups ( p < 0.001). After 48 h of hyperoxia, the h~peroxia in all groups, although the change was less impressive total clinicopathologic score and its five components were signif-in the PEG-SOD/catalase group. The rationale is unclear, but icantly lower for rats treated with PEG-SOD/catalase than for this phenomenon might be partially secondary to release of the treated controls ( Table 1) . Neutrophil and alveolar macro-surfactant by type 11 cells into the alveolar space and cellular phage counts in the first alveolar wash were five to six times i n J u '~ higher in the three treated control groups than in the PEG-SOD/ Treatment of respiratory distress syndrome with surfactant catalase and untreated air controls.
reduces the need for ventilatory support, but lung immaturity The mean survival time in >95% oxygen was 60.2 + 3.7 h in often necessitates prolonged ventilatory assistance in the Very the saline group and 79.7 + 5.1 h in rats pretreated with PEG-preterm infant. and therefore surfactant therapy reduces the risk SOD/catalase ( p < 0.00 1). In each of the eight rat pairs, survival of chronic lung injury only moderately (34) . Combining longwas prolonged in the rats pretreated with PEG-antioxidants.
acting antioxidants with surfactant treatment optimizes drug delivery to the alveolar lining fluid. Liposome-encapsulated SOD DISCUSSION and catalase have been used successfully in rivo and in vitro (10) (11) (12) (13) (14) , but preparation of liposomes is complicated. whereas PEGThe significant increase in the alveolar wash protein content antioxidants are easy to produce, are stable, preserve host-defense of rats pretreated with inactive PEG-SOD/catalase, 1 % PEG, or mechanisms, and provide resistance to intracellular degradation by proteolysis (9. 15. 35) . Furthermore. PEG itself can inactivate hydroxyl radicals in rirro (9) . Dose-response relations were not explored in this study. but the dosages of PEG-SOD/catalase were similar to those used by Padmanabhan et a/. (14) . who encapsulated SOD or catalase in liposomes made from a mixture of phosphatidylcholine and phosphatidylserine. We used a combination of PEG-SOD and PEG-catalase because White er a/. (9) found that only treatment with both compounds(20 000 U PEG-SOD and 400 000 U PEG-catalase i.v.) increased survival and decreased lung injury and neutrophil recruitment and activation in rats exposed to hyperoxia. We used only a fraction of these doses intratracheally and obtained survival times in hyperoxia comparable with those found by White et a/. (9) and Padmanabhan er a/. (14) . Repetitive dosing might further improve the clinical effects of intratracheally instilled PEG-antioxidants, but it was not explored.
These data indicate that intratracheal instillation of PEGconjugated antioxidant enzymes is beneficial in maintaining normal levels of protection from pulmonary oxygen toxicity and on par with liposome-encapsulated antioxidants. Doses. dosing schedules. and efficacy in premature animals need further exploration.
